vimarsana.com

Page 16 - கனடா தொழில்துறை ஆராய்ச்சி உதவி ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Qu Biologics Receives Funding for COVID-19 Prevention/Treatment Research with Qu s Novel Immunotherapy Platform – IT Business Net

Qu Biologics Receives Funding for COVID-19 Prevention/Treatment Research with Qu s Novel Immunotherapy Platform – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Qu Biologics Receives Funding for COVID-19 Prevention/Treatment Research with Qu s Novel Immunotherapy Platform - Press Release

Qu Biologics Receives Funding for COVID-19 Prevention/Treatment Research with Qu s Novel Immunotherapy Platform - Press Release
digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.

Soricimed to Investigate the Potential Benefit of SOR-C13 in the Treatment of COVID-19

Share this article Share this article MONCTON, NB, Dec. 17, 2020 /CNW/ - Soricimed Biopharma Inc., ( Soricimed ), a privately-held, science-based, clinical stage company focused on the development and commercialization of first-in-class targeted cancer therapeutics, today announced that it will investigate the potential therapeutic role its cancer drug candidate, SOR-C13, can play in helping relieve or prevent severe immune response to the SARS CoV-2 virus. Soricimed is currently developing SOR-C13, a TRPV6 calcium channel inhibitor, for the treatment of solid-tumour cancers. SOR-C13 is designed to decrease calcium concentrations inside cancer cells to inhibit calcium-dependent cancer cell proliferation and induce the death of tumour cells overexpressing TRPV6.

Loyalist College and KAT working towards a sustainable cannabis beverage solution

Author of the article: Postmedia Staff Publishing date: Dec 17, 2020  •  December 17, 2020  •  2 minute read  •  Article content Loyalist College and Kingston Aluminum Technology Incorporated are one step closer to creating a sustainable cannabis beverage bottling solution. Loyalist College’s Applied Research Centre for Natural Products and Medical Cannabis has been utilizing their expertise in green technology and cannabis to determine and test alternative sustainable liner options to match the quality of KAT’s recyclable aluminum bottles. We apologize, but this video has failed to load. Try refreshing your browser. Loyalist College and KAT working towards a sustainable cannabis beverage solution Back to video

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.